Cargando…

Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals

BACKGROUND: To systematically examine the clinical utility of tau-PET and Braak-staging as prognostic markers of future cognitive decline in older adults with and without cognitive impairment. METHODS: In this longitudinal study, we included 396 cognitively normal to dementia subjects with (18)F-Flo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biel, Davina, Brendel, Matthias, Rubinski, Anna, Buerger, Katharina, Janowitz, Daniel, Dichgans, Martin, Franzmeier, Nicolai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361801/ https://www.ncbi.nlm.nih.gov/pubmed/34384484 http://dx.doi.org/10.1186/s13195-021-00880-x

Ejemplares similares

Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease
por: Biel, Davina, et al.
Publicado: (2022)

Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading
por: Frontzkowski, Lukas, et al.
Publicado: (2022)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
por: Rubinski, Anna, et al.
Publicado: (2020)

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
por: Pichet Binette, Alexa, et al.
Publicado: (2022)

KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
por: Neitzel, Julia, et al.
Publicado: (2021)

sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
por: Biel, Davina, et al.
Publicado: (2023)

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
por: Franzmeier, Nicolai, et al.
Publicado: (2019)

Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer’s disease
por: Franzmeier, Nicolai, et al.
Publicado: (2020)

Multicenter (18)F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
por: Rullmann, Michael, et al.
Publicado: (2022)

The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework
por: Macedo, Arthur C., et al.
Publicado: (2023)

Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease
por: Rubinski, Anna, et al.
Publicado: (2022)

Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer’s disease
por: Fernández Arias, Jaime, et al.
Publicado: (2023)

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
por: Ossenkoppele, Rik, et al.
Publicado: (2022)

Braiding Braak and Braak: Staging patterns and model selection in network neurodegeneration
por: Putra, Prama, et al.
Publicado: (2021)

Tau plasma levels in subjective cognitive decline: Results from the DELCODE study
por: Müller, Stephan, et al.
Publicado: (2017)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

Left Frontal Hub Connectivity during Memory Performance Supports Reserve in Aging and Mild Cognitive Impairment
por: Franzmeier, Nicolai, et al.
Publicado: (2017)

Association of plasma P-tau181 with memory decline in non-demented adults
por: Therriault, Joseph, et al.
Publicado: (2021)

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
por: Franzmeier, Nicolai, et al.
Publicado: (2020)

Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects
por: Pereira, Joana B, et al.
Publicado: (2021)

P-tau and neurodegeneration mediate the effect of β-amyloid on cognition in non-demented elders
por: Ma, Ling-Zhi, et al.
Publicado: (2021)

The Clock Drawing Test as a predictor of cognitive decline in non-demented stroke patients
por: Cova, Ilaria, et al.
Publicado: (2021)

Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
por: Therriault, Joseph, et al.
Publicado: (2022)

The prion hypothesis in Parkinson's disease: Braak to the future
por: Visanji, Naomi P, et al.
Publicado: (2013)

Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
por: Hall, James R., et al.
Publicado: (2021)

Gain in Brain Immunity in the Oldest-Old Differentiates Cognitively Normal from Demented Individuals
por: Katsel, Pavel, et al.
Publicado: (2009)

Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration
por: Franzmeier, Nicolai, et al.
Publicado: (2020)

Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults
por: Ennis, Gilda E., et al.
Publicado: (2021)

Association between cumulative smoking exposure and cognitive decline in non-demented older adults: NEDICES study
por: Benito-León, Julián, et al.
Publicado: (2023)

Exploring Braak’s Hypothesis of Parkinson’s Disease
por: Rietdijk, Carmen D., et al.
Publicado: (2017)

Predicting cognitive dysfunction and regional hubs using Braak staging amyloid-beta biomarkers and machine learning
por: Bhattarai, Puskar, et al.
Publicado: (2023)

Amyloid-β levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy
por: Oberstein, Timo Jan, et al.
Publicado: (2022)

Cognitive dysfunction in non-demented patients with Parkinson's disease
por: Zalonis, Ioannis, et al.
Publicado: (2010)

CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer’s disease
por: Hunt, Aoife, et al.
Publicado: (2006)

Alzheimer’s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline
por: Bucci, Marco, et al.
Publicado: (2021)

Associations between NIH Toolbox Cognition Battery and in vivo brain amyloid and tau pathology in non‐demented older adults
por: Snitz, Beth E., et al.
Publicado: (2020)

Association of Peripheral Interleukin-6 with Global Cognitive Decline in Non-demented Adults: A Meta-Analysis of Prospective Studies
por: Bradburn, Steven, et al.
Publicado: (2018)

Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment
por: Bainbridge, Wilma A., et al.
Publicado: (2019)

FMRI Complexity Correlates with Tau-PET and Cognitive Decline in Late-Onset and Autosomal Dominant Alzheimer’s Disease
por: Jann, Kay, et al.
Publicado: (2023)

APOE ε4 allele accelerates age-related multi-cognitive decline and white matter damage in non-demented elderly
por: Sun, Jinping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dunmvfmqm5epl9f08bq8b17ojv